Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.

NCT00222261 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1001

Enrollment

OTHER

Sponsor class

Conditions

Coronary Heart Disease
Angina Pectoris
Atherosclerosis

Interventions

DRUG: aspirin
DRUG: clopidogrel

Sponsor

Ullevaal University Hospital

Collaborators

[object Object]
[object Object]
[object Object]